Source: The Street
By Bob Lenihan
Regeneron is starting late-stage trials of a cocktail designed to treat and prevent coronavirus.
Regeneron (REGN) – Get Report said Monday it had started late-stage clinical trials evaluating Regn-Cov2, the biopharma’s double antibody cocktail to treat and prevent coronavirus.
Shares of the Tarrytown, N.Y., company at last check were up 3.7% to $645.14.
The trial, run jointly with the National Institute of Allergy and Infectious Diseases, would test the cocktail’s ability to prevent infection in 2,000 people who have been exposed to the virus by close contact, such as by housemates.
The company said that a separate Phase II/III trial is testing the antibody cocktail therapy as a treatment in 2,900 coronavirus patients who are in hospitals and ambulatory settings. That trial is being run in the U.S. and in other countries like Brazil and Mexico.
“We are running simultaneous adaptive trials in order to move as quickly as possible to provide a potential solution to prevent and treat covid-19 infections,” George Yancopoulos, co-founder, president and chief scientific officer, said in a statement.
Last week, Regeneron and Sanofi (SNY) – Get Report said a group of covid-19 patients requiring mechanical ventilation failed to show measurable improvement when treated in a Phase III trial with the rheumatoid arthritis treatment Kevzara.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE